Documents

RDC 660/2022: import of cannabis products by the patient

Anvisa's RDC 660/2022: rules to import cannabis products directly by the patient, with a medical prescription. Understand the process, timelines and access.

RDC 327/2019: manufacturing and sale of cannabis products

Anvisa's RDC 327/2019: rules for manufacturing, importing and selling cannabis products in pharmacies. To be replaced by RDC 1,015/2026.

RDC 1,011/2026: list update that enables cannabis cultivation

Anvisa's RDC 1,011/2026 updates the Ordinance 344/98 lists and enables cannabis cultivation and research in Brazil. In force on August 4, 2026.

RDC 1,012/2026: cultivation of Cannabis sativa for research

Anvisa's RDC 1,012/2026 sets the requirements for cultivating Cannabis sativa for scientific research in Brazil. In force on August 4, 2026.

RDC 1,013/2026: commercial hemp cultivation (THC ≤ 0.3%)

Anvisa's RDC 1,013/2026 authorizes commercial hemp cultivation (THC ≤ 0.3%) for medical and research purposes. In force on August 4, 2026.

RDC 1,014/2026: the medical cannabis regulatory sandbox

Anvisa's RDC 1,014/2026 creates the regulatory sandbox: an experimental environment for cultivating and preparing medical cannabis. Already in force.

RDC 1,015/2026: the new framework for manufacturing and importing cannabis products

Anvisa's RDC 1,015/2026 is the new framework for manufacturing, importing and dispensing cannabis products, replacing RDC 327. In force in May 2026.

MAPA Ordinance 1,342/2025: import of Cannabis sativa seeds

MAPA Ordinance 1,342/2025: phytosanitary requirements for importing Cannabis sativa seeds in Brazil. Understand the rules and the impact.